Teruna J. Siahaan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Teruna J. Siahaan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Soma Chakrabarti
Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, USA
2 shared publicationsBogdanowich‐ Knipp
Department of Pharmaceutical Chemistry, Simons Research Laboratories, The University of Kansas, Lawrence 66047, USA
1 shared publicationD L Thompson
1 shared publicationD.S. Seetharama Jois
Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, USA
1 shared publicationD.S.S. Jois
1 shared publicationK L Lutz
Department of Pharmaceutical Chemistry, Simons Laboratories, University of Kansas Lawrence 66047, USA
1 shared publication
Latest Publications
- 12 January 2009
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 49 (1) , 15-22
Conformational analysis of cyclo(2,9)-Ac-QCRSVEGSCG-OH from the C-terminal loop of human growth hormone
- 12 January 2009
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 49 (1) , 15-22
Conformational analysis of cyclo(2,9)-Ac-QCRSVEGSCG-OH from the C-terminal loop of human growth hormone
- 1 May 1999
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 53 (5) , 530-541
Solution stability of linear vs. cyclic RGD peptides
Arg‐Gly‐Asp (RGD) peptides contain an aspartic acid residue that is highly susceptible to chemical degradation and leads to the loss of biological activity. Our hypothesis is that cyclization of RGD peptides via disulphide bond linkage can induce structural rigidity, thereby preventing degradation mediated by the aspartic acid residue. In this paper, we compared the solution stability of a linear peptide (Arg‐Gly‐Asp‐Phe‐OH; 1) and a cyclic peptide (cyclo‐(1, 6)‐Ac‐Cys‐Arg‐Gly‐Asp‐Phe‐Pen‐NH2;2) as a function of pH and buffer concentration. The decomposition of both peptides was studied in buffers ranging from pH 2–12 at 50°C. Reversed‐phase HPLC was used as the main tool in determining the degradation rates and pathways of both peptides. Fast atom bombardment mass spectrometry (FAB‐MS), electrospray ionization mass spectrometry (ESI‐MS), matrix‐assisted laser desorption/ionization‐time of flight (MALDI‐TOF) mass spectrometry, liquid chromatography‐mass spectrometry (LC‐MS), and one‐ and two‐dimensional nuclear magnetic resonance spectroscopy (NMR) were used to characterize peptides 1 and 2 and their degradation products. In addition, co‐elution with authentic samples was used to identify degradation products. Both peptides displayed pseudo‐first‐order kinetics at all pH values studied. The cyclic peptide 2 appeared to be 30‐fold more stable than the linear peptide 1 at pH 7. The degradation mechanisms of linear (1) and cyclic (2) peptides primarily involved the aspartic acid residue. However, above pH 8 the stability of the cyclic peptide decreased dramatically due to disulphide bond degradation. Both peptides also exhibited a change in degradation mechanism upon an increase in pH. The increase in stability of cyclic peptide 2 compared to linear peptide 1, especially at neutral pH, may be due to decreased structural flexibility imposed by the ring. This rigidity would prevent the Asp side chain carboxylic acid from orientating itself in the appropriate position for attack on the peptide backbone.
- 1 May 1999
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 53 (5) , 530-541
Solution stability of linear vs. cyclic RGD peptides
Arg‐Gly‐Asp (RGD) peptides contain an aspartic acid residue that is highly susceptible to chemical degradation and leads to the loss of biological activity. Our hypothesis is that cyclization of RGD peptides via disulphide bond linkage can induce structural rigidity, thereby preventing degradation mediated by the aspartic acid residue. In this paper, we compared the solution stability of a linear peptide (Arg‐Gly‐Asp‐Phe‐OH; 1) and a cyclic peptide (cyclo‐(1, 6)‐Ac‐Cys‐Arg‐Gly‐Asp‐Phe‐Pen‐NH2;2) as a function of pH and buffer concentration. The decomposition of both peptides was studied in buffers ranging from pH 2–12 at 50°C. Reversed‐phase HPLC was used as the main tool in determining the degradation rates and pathways of both peptides. Fast atom bombardment mass spectrometry (FAB‐MS), electrospray ionization mass spectrometry (ESI‐MS), matrix‐assisted laser desorption/ionization‐time of flight (MALDI‐TOF) mass spectrometry, liquid chromatography‐mass spectrometry (LC‐MS), and one‐ and two‐dimensional nuclear magnetic resonance spectroscopy (NMR) were used to characterize peptides 1 and 2 and their degradation products. In addition, co‐elution with authentic samples was used to identify degradation products. Both peptides displayed pseudo‐first‐order kinetics at all pH values studied. The cyclic peptide 2 appeared to be 30‐fold more stable than the linear peptide 1 at pH 7. The degradation mechanisms of linear (1) and cyclic (2) peptides primarily involved the aspartic acid residue. However, above pH 8 the stability of the cyclic peptide decreased dramatically due to disulphide bond degradation. Both peptides also exhibited a change in degradation mechanism upon an increase in pH. The increase in stability of cyclic peptide 2 compared to linear peptide 1, especially at neutral pH, may be due to decreased structural flexibility imposed by the ring. This rigidity would prevent the Asp side chain carboxylic acid from orientating itself in the appropriate position for attack on the peptide backbone.
- 1 May 1999
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 53 (5) , 523-529
The effect of conformation on the solution stability of linear vs. cyclic RGD peptides
The objective of this study was to evaluate the relationship between conformational flexibility and solution stability of a linear RGD peptide (Arg‐Gly‐Asp‐Phe‐OH; 1) and a cyclic RGD peptide (cyclo‐(1, 6)‐Ac‐Cys‐Arg‐Gly‐Asp‐Phe‐Pen‐NH2; 2); as a function of pH. Previously, it was found that cyclic peptide 2 was 30‐fold more stable than linear peptide 1. Therefore, this study was performed to explain the increase in chemical stability based on the preferred conformation of the peptides. Molecular dynamics simulations and energy minimizations were conducted to evaluate the backbone flexibility of both peptides under simulated pH conditions of 3, 7 and 10 in the presence of water. The reactive sites for degradation for both molecules were also followed during the simulations. The backbone of linear peptide 1 exhibited more flexibility than that of cyclic peptide 2, which was reflected in the rotation about the phi and psi dihedral angles. This was further supported by the low r.m.s. deviations of the backbone atoms for peptide 2 compared with those of peptide 1 that were observed among structures sampled during the molecular dynamics simulations. The presence of a salt bridge between the side chain groups of the Arg and Asp residues was also indicated for the cyclic peptide under simulated conditions of neutral pH. The increase in stability of the cyclic peptide 2 compared with the linear peptide 1, especially at neutral pH, is due to decreased structural flexibility imposed by the ring, as well as salt bridge formation between the side chains of the Arg and Asp residues in cyclic peptide 2. This rigidity would prevent the Asp side chain carboxylic acid from orienting itself in the appropriate position for attack on the peptide backbone.
- 1 May 1999
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 53 (5) , 523-529
The effect of conformation on the solution stability of linear vs. cyclic RGD peptides
The objective of this study was to evaluate the relationship between conformational flexibility and solution stability of a linear RGD peptide (Arg‐Gly‐Asp‐Phe‐OH; 1) and a cyclic RGD peptide (cyclo‐(1, 6)‐Ac‐Cys‐Arg‐Gly‐Asp‐Phe‐Pen‐NH2; 2); as a function of pH. Previously, it was found that cyclic peptide 2 was 30‐fold more stable than linear peptide 1. Therefore, this study was performed to explain the increase in chemical stability based on the preferred conformation of the peptides. Molecular dynamics simulations and energy minimizations were conducted to evaluate the backbone flexibility of both peptides under simulated pH conditions of 3, 7 and 10 in the presence of water. The reactive sites for degradation for both molecules were also followed during the simulations. The backbone of linear peptide 1 exhibited more flexibility than that of cyclic peptide 2, which was reflected in the rotation about the phi and psi dihedral angles. This was further supported by the low r.m.s. deviations of the backbone atoms for peptide 2 compared with those of peptide 1 that were observed among structures sampled during the molecular dynamics simulations. The presence of a salt bridge between the side chain groups of the Arg and Asp residues was also indicated for the cyclic peptide under simulated conditions of neutral pH. The increase in stability of the cyclic peptide 2 compared with the linear peptide 1, especially at neutral pH, is due to decreased structural flexibility imposed by the ring, as well as salt bridge formation between the side chains of the Arg and Asp residues in cyclic peptide 2. This rigidity would prevent the Asp side chain carboxylic acid from orienting itself in the appropriate position for attack on the peptide backbone.
- 1 September 1996
- Vol. 9 (5) , 233-9
Antibody recognition of peptide sequences from the cell-cell adhesion proteins: N- and E-cadherins.
Intercellular junctions present a formidable challenge for the paracellular delivery of drugs. Cadherins are calcium-dependent cell-cell adhesion molecules, which are responsible for the formation and regulation of these junctions. Anti-E-cadherin monoclonal antibody can bind to E-cadherin (uvomorulin) and inhibit cell-cell adhesion through the inhibition of cadherin-cadherin interactions. The objective of this study was to utilize this monoclonal anti-E-cadherin antibody to map the extracellular domains of E- and N-cadherin. This was accomplished by using two different enzyme-linked immunosorbent assays (ELISAs), a regular indirect ELISA and an immobilized-peptide ELISA. Two peptides from each extracellular domain were recognized by this anti-E-cadherin antibody. By mapping the extracellular domains of cadherins, peptides that have discrete roles in cell-cell adhesion can be identified. This will aid in the design of synthetic peptides that can modulate intercellular junctions to improve drug delivery.
- 1 September 1996
- Vol. 9 (5) , 233-9
Antibody recognition of peptide sequences from the cell-cell adhesion proteins: N- and E-cadherins.
Intercellular junctions present a formidable challenge for the paracellular delivery of drugs. Cadherins are calcium-dependent cell-cell adhesion molecules, which are responsible for the formation and regulation of these junctions. Anti-E-cadherin monoclonal antibody can bind to E-cadherin (uvomorulin) and inhibit cell-cell adhesion through the inhibition of cadherin-cadherin interactions. The objective of this study was to utilize this monoclonal anti-E-cadherin antibody to map the extracellular domains of E- and N-cadherin. This was accomplished by using two different enzyme-linked immunosorbent assays (ELISAs), a regular indirect ELISA and an immobilized-peptide ELISA. Two peptides from each extracellular domain were recognized by this anti-E-cadherin antibody. By mapping the extracellular domains of cadherins, peptides that have discrete roles in cell-cell adhesion can be identified. This will aid in the design of synthetic peptides that can modulate intercellular junctions to improve drug delivery.